Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Glycoconjugate Journal

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10719-006-7924-4PMID 16691502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells

  2004cited by this paper
• Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

  2004influential reference
• The HIV Env-mediated fusion reaction.

  2003cited by this paper
• Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review)

  2003cited by this paper
• Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity

  2002cited by this paper
• Role for Human Immunodeficiency Virus Type 1 Membrane Cholesterol in Viral Internalization

  2002cited by this paper
• Lipids in viral fusion.

  2002influential reference
• Role of Cholesterol in Human Immunodeficiency Virus Type 1 Envelope Protein-Mediated Fusion with Host Cells

  2002cited by this paper
• Cholesterol depletion induces large scale domain segregation in living cell membranes

  2001cited by this paper
• Lipid Rafts and HIV Pathogenesis: Host Membrane Cholesterol Is Required for Infection by HIV Type 1

  2001cited by this paper
• Plasma membrane rafts play a critical role in HIV-1 assembly and release

  2001cited by this paper
• Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol.

  2001cited by this paper
• Entry of influenza virus into a glycosphingolipid-deficient mouse skin fibroblast cell line

  2001cited by this paper
• HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process.

  2001cited by this paper
• CCR5, CXCR4, and CD4 Are Clustered and Closely Apposed on Microvilli of Human Macrophages and T Cells

  2001cited by this paper
• Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection

  2000cited by this paper
• Cell biology of virus entry.

  2000cited by this paper
• Glycosphingolipids Promote Entry of a Broad Range of Human Immunodeficiency Virus Type 1 Isolates into Cell Lines Expressing CD4, CXCR4, and/or CCR5

  2000influential reference
• Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion

  2000cited by this paper
• Gp120 Binds Cooperatively to Several Biologically Relevant Glycosphingolipids: Quantitative Measurements at Equilibrium by Total Internal Reflection Fluorescence Microscopy This research was supported by the NIH (AI40359-02), the NSF (CHE-9726132 and CHE-9623583), Eli Lilly (JGH), and the Alfred P.

  2000cited by this paper
• Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3)

  1999influential reference
• CD4 segregates into specific detergent-resistant T-cell membrane microdomains.

  1999cited by this paper
• Chemotherapy by slowing glucosphingolipid synthesis.

  1999cited by this paper
• The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

  1998cited by this paper
• HIV entry and its inhibition.

  1998cited by this paper
• Specific Interaction of HIV-1 and HIV-2 Surface Envelope Glycoproteins with Monolayers of Galactosylceramide and Ganglioside GM3*

  1998cited by this paper
• Dilation of the Human Immunodeficiency Virus–1 Envelope Glycoprotein Fusion Pore Revealed by the Inhibitory Action of a Synthetic Peptide from gp41

  1998cited by this paper
• Actin-Dependent Receptor Colocalization Required for Human Immunodeficiency Virus Entry into Host Cells

  1998cited by this paper
• The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.

  1998influential reference
• Functions of lipid rafts in biological membranes.

  1998cited by this paper
• Conformational Changes in Cell Surface HIV-1 Envelope Glycoproteins Are Triggered by Cooperation between Cell Surface CD4 and Co-receptors*

  1998cited by this paper
• Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes.

  1997cited by this paper
• HIV entry and tropism: the chemokine receptor connection.

  1997cited by this paper
• Functional rafts in cell membranes

  1997cited by this paper
• HIV entry and tropism: the chemokine receptor connection.

  1997cited by this paper
• Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

  1997cited by this paper
• Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages.

  1995cited by this paper
• A Human Lymphoid Recombinant Cell Line with Functional Human Immunodeficiency Virus Type 1 Envelope

  1993cited by this paper
• A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity.

  1992cited by this paper
• Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses

  1991cited by this paper
• Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.

  1984cited by this paper

• Innate sensing and cellular metabolism: role in fine tuning antiviral immune responses.

  2023cites this paper
• Identification of possible binding modes of SARS-CoV-2 spike N -terminal domain for ganglioside GM1

  2022cites this paper
• Identification of possible binding modes of SARS-CoV-2 spike N-terminal domain for ganglioside GM1

  2022cites this paper
• Membrane Rafts: Portals for Viral Entry

  2021cites this paper
• Therapeutic and Vaccine Strategies for Stopping the COVID-19 Pandemic Based on Structural and Molecular Modeling Studies of Virus-Ganglioside Interactions

  2021cites this paper
• The role of cell surface sialic acids for SARS-CoV-2 infection

  2021cites this paper
• Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19

  2020cites this paper
• Fingolimod inhibits multiple stages of the HIV-1 life cycle

  2020cites this paper
• The role of blood groups in preventing or enhancing HIV infection in Botswana

  2019cites this paper
• A biophysical perspective on receptor-mediated virus entry with a focus on HIV

  2019cites this paper
• Lipid rafts and pathogens: the art of deception and exploitation

  2019cites this paper
• Membrane Dynamics in Health and Disease: Impact on Cellular Signalling

  2019cites this paper
• A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life

  2019cites this paper
• Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses

  2018cites this paper
• Erythrocyte Lysate from HIV-1-Infected Individuals Contains HIV-1 RNA

  2018cites this paper
• Mapping out the intricate relationship of the HIV envelope protein and the membrane environment.

  2017cites this paper
• Role of cellular metabolism in regulating type I interferon responses: Implications for tumour immunology and treatment.

  2017cites this paper
• Development of potent and long-acting HIV-1 fusion inhibitors

  2016cites this paper
• Mécanismes de résistance aux inhibiteurs de CCR5

  2015cites this paper
• Therapeutic Strategies for Neurodegenerative Diseases

  2015cites this paper
• Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site

  2014cites this paper
• Molecular Mediators for Raft-dependent Endocytosis of Syndecan-1, a Highly Conserved, Multifunctional Receptor*

  2013cites this paper
• Sphingopeptides: dihydrosphingosine‐based fusion inhibitors against wild‐type and enfuvirtide‐resistant HIV‐1

  2012cites this paper
• Function of Membrane Rafts in Viral Lifecycles and Host Cellular Response

  2011cites this paper
• Glycosphingolipids in HIV/AIDS: The Potential Therapeutic Application

  2011cites this paper
• Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.

  2011cites this paper
• Thermal Stability of the Human Immunodeficiency Virus Type 1 (HIV-1) Receptors, CD4 and CXCR4, Reconstituted in Proteoliposomes

  2010cites this paper
• Implications for lipids during replication of enveloped viruses

  2010cites this paper
• Lipids in host–pathogen interactions: Pathogens exploit the complexity of the host cell lipidome

  2009cites this paper
• Ceramide activates JNK to inhibit a cAMP‐gated K+ conductance and Cl‐ secretion in intestinal epithelia

  2009cites this paper
• Role of Membrane Rafts in Viral Infection

  2009cites this paper
• Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion

  2008cites this paper
• Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.

  2008cites this paper
• Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog*

  2008cites this paper
• Lipids as modulators of membrane fusion mediated by viral fusion proteins

  2007cites this paper
• Biophysical characterization of V3-lipopeptide liposomes influencing HIV-1 infectivity.

  2007cites this paper
• Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms.

  2007cites this paper
• Conversion of apical plasma membrane sphingomyelin to ceramide attenuates the intoxication of host cells by cholera toxin

  2007cites this paper
• The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion

  2006cites this paper